News
Stay up to date with the latest discoveries in structured real-world data, oncology analytics and AI-powered research.
Insights
Featured News
Stay up to date with the latest discoveries in structured real-world data, oncology analytics and AI-powered research.
Articles
23 Apr, 2026
Key Takeaways A New Signal from Europe Across Europe, there are renewed signs of momentum in healthcare innovation and Spain […]
Articles
21 Apr, 2026
By Vasko Graklanov, MD, PhD, MPH This expert commentary is part of Sqilline Health’s ongoing effort to advance real-world evidence […]
Case Studies
21 Apr, 2026
A leading oncology center in Poland partnered with Sqilline to tackle one of the most persistent challenges in lung cancer […]
Insights
Our Latest Insights
Stay up to date with the latest discoveries in structured real-world data, oncology analytics and AI-powered research.
Articles
23 Apr, 2026
Key Takeaways A New Signal from Europe Across Europe, there are renewed signs of momentum in healthcare innovation and Spain […]
Articles
21 Apr, 2026
By Vasko Graklanov, MD, PhD, MPH This expert commentary is part of Sqilline Health’s ongoing effort to advance real-world evidence […]
Case Studies
21 Apr, 2026
A leading oncology center in Poland partnered with Sqilline to tackle one of the most persistent challenges in lung cancer […]
Articles
21 Apr, 2026
Across Europe, oncology is becoming increasingly data-driven, yet the maturity of data ecosystems still varies widely. In Romania, the field […]
Articles
7 Apr, 2026
Prof. Dragan Trivanović explores how the growing complexity of oncology is reshaping the role of data, technology, and multidisciplinary collaboration […]
Articles
6 Apr, 2026
Dr. Enrique Grande discusses how better use of clinical data can improve cancer care, support scientific progress, and strengthen evidence-based […]
Articles
26 Mar, 2026
Key Takeaways The uncomfortable truth: oncology is data-rich, but insight-poor Across Europe, oncology generates vast amounts of clinical data every […]
Articles
17 Mar, 2026
Randomized clinical trials remain the cornerstone of evidence generation, but in rare diseases they often face fundamental limitations, including small […]